Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
1.660
0.00 (0.00%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Rapid Micro Biosystems Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 35.18 | 33.59 | 28.05 | 22.52 | 17.13 | 23.23 | |
Revenue Growth | 16.13% | 19.73% | 24.57% | 31.44% | -26.25% | 44.51% |
Cost of Revenue | 33.23 | 32.54 | 28.16 | 28 | 25.67 | 30.97 |
Gross Profit | 1.95 | 1.05 | -0.11 | -5.49 | -8.54 | -7.74 |
Selling, General & Admin | 38.27 | 34.84 | 35.21 | 38.26 | 41.81 | 29.71 |
Research & Development | 13.44 | 13.6 | 14.6 | 12.82 | 12.87 | 9.78 |
Operating Expenses | 51.71 | 48.44 | 49.81 | 51.08 | 54.68 | 39.49 |
Operating Income | -49.76 | -47.39 | -49.92 | -56.56 | -63.22 | -47.23 |
Interest Expense | -2.35 | -1.09 | -0.04 | - | - | -2.61 |
Interest & Investment Income | 1.09 | 1.51 | 3.2 | 4.21 | 1.78 | - |
Other Non Operating Income (Expenses) | -0.11 | -0.11 | -0.11 | -0.08 | 0.06 | -19.64 |
EBT Excluding Unusual Items | -51.13 | -47.08 | -46.87 | -52.44 | -61.38 | -69.48 |
Other Unusual Items | - | - | - | - | - | -3.95 |
Pretax Income | -51.13 | -47.08 | -46.87 | -52.44 | -61.38 | -73.43 |
Income Tax Expense | 0.08 | 0.04 | 0.02 | 0.03 | -0.58 | 0.09 |
Net Income | -51.2 | -47.12 | -46.89 | -52.47 | -60.81 | -73.52 |
Preferred Dividends & Other Adjustments | - | - | - | - | - | 4.51 |
Net Income to Common | -51.2 | -47.12 | -46.89 | -52.47 | -60.81 | -78.03 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 46 | 45 | 44 | 43 | 42 | 20 |
Shares Outstanding (Diluted) | 46 | 45 | 44 | 43 | 42 | 20 |
Shares Change | 4.55% | 2.53% | 1.28% | 1.34% | 114.59% | 5417.16% |
EPS (Basic) | -1.11 | -1.05 | -1.08 | -1.22 | -1.43 | -3.94 |
EPS (Diluted) | -1.11 | -1.05 | -1.08 | -1.22 | -1.43 | -3.94 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -40.39 | -31.91 | -45.52 | -46.93 | -65.29 | -58.18 |
Free Cash Flow Per Share | -0.88 | -0.71 | -1.04 | -1.09 | -1.54 | -2.94 |
Gross Margin | 5.55% | 3.12% | -0.39% | -24.36% | -49.84% | -33.32% |
Operating Margin | -141.45% | -141.10% | -177.96% | -251.18% | -368.99% | -203.31% |
Profit Margin | -145.55% | -140.30% | -167.16% | -232.99% | -354.91% | -335.88% |
Free Cash Flow Margin | -114.83% | -95.01% | -162.27% | -208.38% | -381.06% | -250.44% |
EBITDA | -47.08 | -44.64 | -46.96 | -53.76 | -60.68 | -45.8 |
EBITDA Margin | -133.85% | -132.91% | -167.40% | -238.72% | - | -197.16% |
D&A For EBITDA | 2.67 | 2.75 | 2.96 | 2.81 | 2.54 | 1.43 |
EBIT | -49.76 | -47.39 | -49.92 | -56.56 | -63.22 | -47.23 |
EBIT Margin | -141.45% | -141.10% | -177.96% | -251.18% | - | -203.31% |
Revenue as Reported | 35.18 | 33.59 | 28.05 | 22.52 | 17.13 | 23.23 |
Advertising Expenses | - | 0.2 | 0.2 | 0.3 | 0.1 | 0.1 |